Aurora Cannabis (ACB) Non-Current Deferred Tax Liability (2018 - 2025)
Aurora Cannabis (ACB) posted quarterly Non-Current Deferred Tax Liability of $2.5 million for Q4 2025, up 269.28% year-over-year from $675761.6 in Q4 2024, and down 1.37% quarter-over-quarter from $2.5 million in Q3 2025.
Aurora Cannabis (ACB) Non-Current Deferred Tax Liability (2018 - 2025) Analysis & Trends
Aurora Cannabis (ACB) has reported Non-Current Deferred Tax Liability for 8 consecutive years, with $2.5 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Non-Current Deferred Tax Liability rose 269.28% year-over-year to $2.5 million; the TTM figure through Dec 2025 stood at $2.5 million (up 269.28% YoY), while the FY2025 annual figure was $1.4 million, up 1194.95% from the prior year.
- Non-Current Deferred Tax Liability slipped to $2.5 million in Q4 2025 per ACB's latest filing, from $2.5 million in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at $30.5 million in Q1 2023 and bottomed at $105380.1 in Q1 2024.
- Historically, Non-Current Deferred Tax Liability has averaged $9.5 million across 5 years, with a median of $11.4 million in 2024.
- Annual changes were most pronounced in 2024 — Non-Current Deferred Tax Liability sank 99.65% — and 2025, when it soared 1154.55%.
- Aurora Cannabis' Non-Current Deferred Tax Liability stood at $24.1 million in 2021, then plunged by 49.93% to $12.1 million in 2022, then fell by 0.62% to $12.0 million in 2023, then plunged by 94.37% to $675761.6 in 2024, then surged by 269.28% to $2.5 million in 2025.
- Business Quant data shows ACB's Non-Current Deferred Tax Liability at $2.5 million in Q4 2025, $2.5 million in Q3 2025, and $1.4 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Aurora Cannabis | 233.45 Mn | 161.14 Mn | 25.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.50 Mn |
| Dec 31, 2025 | 2.50 Mn |
| Sep 30, 2025 | 2.53 Mn |
| Sep 30, 2025 | 2.53 Mn |
| Jun 30, 2025 | 1.38 Mn |
| Jun 30, 2025 | 1.38 Mn |
| Mar 31, 2025 | 1.32 Mn |
| Mar 31, 2025 | 1.32 Mn |
| Dec 31, 2024 | 675,761.59 |
| Dec 31, 2024 | 675,761.59 |
| Sep 30, 2024 | 11.37 Mn |
| Sep 30, 2024 | 11.37 Mn |
| Jun 30, 2024 | 12.86 Mn |
| Jun 30, 2024 | 12.86 Mn |
| Mar 31, 2024 | 105,380.08 |
| Mar 31, 2024 | 105,380.08 |
| Dec 31, 2023 | 11.99 Mn |
| Dec 31, 2023 | 11.99 Mn |
| Sep 30, 2023 | 12.36 Mn |
| Sep 30, 2023 | 12.36 Mn |